98 related articles for article (PubMed ID: 25056130)
81. Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide.
Nishikawa H; Nakamura S; Kodama E; Ito S; Kajiwara K; Izumi K; Sakagami Y; Oishi S; Ohkubo T; Kobayashi Y; Otaka A; Fujii N; Matsuoka M
Int J Biochem Cell Biol; 2009 Apr; 41(4):891-9. PubMed ID: 18834950
[TBL] [Abstract][Full Text] [Related]
82. Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells.
Löhr M; Kibler KV; Zachary I; Jeang KT; Selwood DL
Biochem Biophys Res Commun; 2003 Jan; 300(2):609-13. PubMed ID: 12504126
[TBL] [Abstract][Full Text] [Related]
83. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
[TBL] [Abstract][Full Text] [Related]
84. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
[TBL] [Abstract][Full Text] [Related]
85. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
86. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
87. Recent status of HIV-1 gene expression inhibitors.
Baba M
Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
[TBL] [Abstract][Full Text] [Related]
88. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
[TBL] [Abstract][Full Text] [Related]
89. Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.
Chandra K; Maes M; Friedler A
Future Med Chem; 2015; 7(8):1055-77. PubMed ID: 26062401
[TBL] [Abstract][Full Text] [Related]
90.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
91.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
92.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
